The ReWalk Robotics, the Israeli creator of the recently FDA-approved exoskeletons that enable paraplegics to walk, has released the terms for its IPO. The company plans to raise $50 million by offering 3.4 million shares at a $14 to $16 price range. ReWalk Robotics would command a fully diluted market value of $191 million, which is lower than former predictions. The company, founded in 2001, has marketed the product in hospitals earning $1.6 million revenue in 2013 and a loss of $12.2 million.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
![](https://nocamels.com/wp-content/uploads/2018/02/INSIGHTEC-350x180.jpg)
Israeli Ultrasound Creator Collaborating On Neuroscience R&D In US
September 05, 2024
![The Weizmann Institute of Science. Photo via the Weizmann Institute of Science](https://nocamels.com/wp-content/uploads/2018/07/weizmann-350x252.jpg)
Weizmann In World’s Top 10 For Biomedical And Overall Research
September 05, 2024
![](https://nocamels.com/wp-content/uploads/2024/09/Depositphotos_75148477_L-350x228.jpg)
Israeli NGO Begins New Mental Health Training In Ukraine
September 04, 2024
![](https://nocamels.com/wp-content/uploads/2024/09/17123254699_79ff768811_ks-350x213.jpg)
Nonprofit Launches Loans For Stricken Northern Israel Businesses
September 04, 2024
Facebook comments